Point72 Asia (Singapore) Pte. Ltd. Y M Abs Therapeutics, Inc. Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $384 Billion
- Q1 2024
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 6,019 shares of YMAB stock, worth $69,760. This represents 0.03% of its overall portfolio holdings.
Number of Shares
6,019Holding current value
$69,760% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding YMAB
# of Institutions
96Shares Held
22.4MCall Options Held
37.4KPut Options Held
48.2K-
Black Rock Inc. New York, NY2.86MShares$33.1 Million0.0% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.23MShares$25.9 Million1.36% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.19MShares$25.4 Million2.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.07MShares$24 Million0.0% of portfolio
-
Polar Capital Holdings PLC London, X01.83MShares$21.2 Million0.19% of portfolio
About Y-mAbs Therapeutics, Inc.
- Ticker YMAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,719,500
- Market Cap $507M
- Description
- Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...